Hip fracture surgery and outcomes
Not Applicable
- Conditions
- Hip fracture surgery complicationsSurgery - Other surgeryBlood - Clotting disorders
- Registration Number
- ACTRN12622000312741
- Lead Sponsor
- sha Gurunathan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 2500
Inclusion Criteria
Adult patients 60 years and above, who underwent surgery for hip fracture at TPCH between the years 2010-2020
Exclusion Criteria
•Hip fracture patients who were managed with non-surgical options
•Those with co-existing fractures in other areas
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link obesity to postoperative thromboembolism in hip fracture patients?
How does standard anticoagulation protocol efficacy vary between obese and non-obese hip fracture surgery patients?
Which biomarkers predict thromboembolic risk in obese individuals undergoing hip fracture repair?
What are the most common postoperative complications in obese hip fracture patients and their management strategies?
How do novel anticoagulant drug classes compare to traditional therapies for obesity-associated venous thromboembolism prevention?